1628
/ 1
Min Read
Lupin, India's third-largest drugmaker, has introduced 'ANYA', a chatbot designed to provide medically verified information for health-related queries. 'ANYA' is the first bot of its kind to be launched in the country for disease awareness.
The chatbot aims to answer patient queries related to ailments. Initially, ANYA will address queries related to diabetes.
This launch is Lupin’s start to digitize the patient journey in the overall healthcare space.
Rajeev Sibal, President - IRF, Lupin, said, "At Lupin, we continue to explore ways to integrate technology to support effective patient care. Chatbot as a technology has enormous potential to aid in medical assistance and to support in building awareness and breaking myths associated with various therapies. We are taking the first step to offer this AI-based chatbot for patients and health-givers and we believe this will be a game changer in the field of disease management in the future. This will also be a significant step in providing better access in rural markets as we adopt and launch digital healthcare platforms for better outreach."
